Printer Friendly
The Free Library
19,573,952 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

CEO INTERVIEW: ROBERT VAN NOSTRAND - OSI PHARMACEUTICALS INC (OSIP).


(PAJ211) ROBERT VAN NOSTRAND - OSI PHARMACEUTICALS INC (OSIP OSIP Open Source Integrated Portfolio
OSIP Open Sip (session initiation protocol)
OSIP Ohio Statewide Imagery Program
OSIP Operational Safety Improvement Program
OSIP Operational Suitability Improvement Program (aviation) 
). Describes the company's business and its background; prospects for the industry, with positive and negative trends; competitive threats; strategic opportunities for the firm including its marketing plans and acquisition potential; management strength and organization; and the financial prospects of the firm looking forward. Sector: Biotechnology. Published date 5/8/02. Tickers featured: OSIP. Complete text approximately 3000 words. Document # PAJ211.

CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board.  INTERVIEWS, The Wall Street Transcript, 67 Wall Street, NY 10005. Voice (212) 952 7433. Fax: (212) 668-9842. E-mail: transcript@twst.com.

***
COPYRIGHT 2002 Wall Street Transcript Corporation
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2002 Gale, Cengage Learning. All rights reserved.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Comment:CEO INTERVIEW: ROBERT VAN NOSTRAND - OSI PHARMACEUTICALS INC (OSIP).(Brief Article)
Publication:Wall Street Transcript Digest
Article Type:Brief Article
Geographic Code:1USA
Date:Jun 10, 2002
Words:90
Previous Article:ANALYST INTERVIEW: BIOTECHNOLOGY & VENTURE CAPITAL: CARL GORDON - ORBIMED ADVISORS LLC.
Next Article:CEO INTERVIEW: EDWARD JACOBS - SUPERGEN INC (SUPG).
Topics:



Related Articles
Robertson Stephens Analysts to Interview On RadioWallStreet Internet Broadcast.
Robertson Stephens Analysts to Interview On RadioWallStreet Internet Broadcast.
COLIN GODDARD - OSI PHARMACEUTICALS INC (OSIP).
CEO INTERVIEW: COLIN GODDARD - OSI PHARMACEUTICALS INC (OSIP).
CEO INTERVIEW: COLIN GODDARD - OSI PHARMACEUTICALS INC (OSIP).
StockPickReport.Com Announces Stock Evaluation Ratings: New Ratings on Championship Auto Racing, Osi Pharmaceuticals Inc, Immunomedics Inc, Cygnus...
CEO INTERVIEW: ROBERT VAN NOSTRAND - OSI PHARMACEUTICALS INC (OSIP).
OSI Pharmaceuticals to Host Conference Call to Discuss (OSI) Eyetech Integration Strategy.
OSI Pharmaceuticals Reports Option Grants Under NASDAQ Marketplace Rule 4350.
OSI Announces Signing of a Commitment Letter for $75 Million Revolving Credit Facility.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles